IP Library Granted Patent US 11,598,024
Granted Patent B2
US 11,598,024 · App. 16/838,910 · Granted Mar 7, 2023

Libraries of genetic packages comprising novel HC CDR1, CDR2, and CDR3 and novel LC CDR1, CDR2, and CDR3 designs

Inventor: Robert Charles Ladner (Ijamsville, MD)
Assignee: Takeda Pharmaceutical Company Limited
C40B40/08C07K16/005C40B40/02C40B40/10C07K2317/565
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,598,024
App. No.
16/838,910
Granted
Mar 7, 2023
Kind
B2
Abstract

Provided are compositions and methods for preparing and identifying antibodies having CDR3s that vary in sequence and in length from very short to very long which in certain embodiments may bind to a carbohydrate moiety or the active site of an enzyme. Libraries coding for antibodies with the CDR3s are also provided. The libraries can be provided by modifying a pre-existing nucleic acid library.

Claims (10)

1. A library of vectors or genetic packages, wherein the vectors or genetic packages comprise variegated DNA sequences, each encoding a heavy chain (HC) variable region, which comprises three complementarity determining regions (CDRs) 1-3 and framework regions (FRs) 1-4, arranged from the amino-terminus to the carboxy-terminus in an order of FR1-CDR2-FR2-CDR2-FR3-CDR3-FR4, wherein the HC CDR3 region contains 3-35 amino acid residues, and wherein more than 20% of the HC CDR3 sequence consists of Tyr residues;

wherein D regions and J stumps of the HC CDR3 consist of more than 20% of Tyr residues;

wherein the D regions are selected from the group consisting of 3-3.2 (SEQ ID NO: 177), 3-22.2 (SEQ ID NO: 88), 6-19.1 (SEQ ID NO: 218), 6-13.1 (SEQ ID NO: 215) and 4-17.2 (SEQ ID NO: 760); and

wherein the J stumps are selected from the libraries consisting of 5.002 (SEQ ID NO: 984), 5.003 (SEQ ID NO: 985), 5.005 (SEQ ID NO: 985) and 5.006 (SEQ ID NO: 990).

2. The library of claim 1 , wherein the library is a library of genetic packages.

3. The library of claim 2 , wherein the genetic packages are bacteriophages.

4. The library of claim 3 , wherein the library is a phage display library.

5. The library of claim 1 , wherein the library is a library of vectors.

6. The library of claim 5 , wherein the vectors are phage vectors or phagemid vectors.

7. The library of claim 1 , wherein the library comprises at least 1×10 9 members.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 18, 2021
From: DYAX CORP.
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 056268/0983 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 1, 2020
From: LADNER, ROBERT C.
To: DYAX CORP.
Reel/Frame 053659/0337 →
Continuity (4)
Division 15177199 · Jun 8, 2016
Continuation 12989307
Provisional Application 61047529 · Apr 24, 2008
Related Publication 20200347117A1 · Nov 5, 2020